Osteoarthritis Trial, Recruiting (NCT06312943)

Osteoarthritis Trial, Recruiting NCT06312943 Sponsor: Assistance Publique - Hôpitaux de Paris Condition: Osteoarthritis

Printed from Voxsanity (voxsanity.com.au) — NCT06312943 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Osteoarthritis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People aged 18 years or older
People with inflammatory or non-inflammatory bone and joint diseases that require either fluid to be drained from a joint or joint replacement surgery
People who have agreed to participate (non-opposition collected)
People who are affiliated with or covered by the French social security system

Who may not be able to join:

People who are unable to speak and/or read French
People who have received neoadjuvant therapy (a type of treatment given before a main treatment, such as chemotherapy before surgery — confirm with trial site)
People who are under legal guardianship or curatorship (a legal arrangement where another person manages their affairs)
People who are classed as legally protected adults under French law
People who receive State Medical Aid (a specific French government healthcare assistance program)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 16 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Christelle Nguyen, MD, PhD, Service de Médecine Physique et de Réadaptation, Hôpital Cochin

Phone: 00 33 1 58 41 29 45

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06312943

Sponsor: Assistance Publique - Hôpitaux de Paris

Phase: Not Applicable

Status: Recruiting

Condition: Osteoarthritis

Trial contact: 00 33 1 58 41 29 45

More information: https://clinicaltrials.gov/study/NCT06312943

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People aged 18 years or older
People with inflammatory or non-inflammatory bone and joint diseases that require either fluid to be drained from a joint or joint replacement surgery
People who have agreed to participate (non-opposition collected)
People who are affiliated with or covered by the French social security system

Who may not be able to join:

People who are unable to speak and/or read French
People who have received neoadjuvant therapy (a type of treatment given before a main treatment, such as chemotherapy before surgery — confirm with trial site)
People who are under legal guardianship or curatorship (a legal arrangement where another person manages their affairs)
People who are classed as legally protected adults under French law
People who receive State Medical Aid (a specific French government healthcare assistance program)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 16 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Assistance Publique - Hôpitaux de Paris

Registry

ClinicalTrials.gov

Start date

2 June 2026

Est. completion

1 June 2029

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Tissues and biofluid spectra using surface-enhanced Raman spectroscopy; Protein expression using immunodetection techniques and RNA expression using PCR

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov